SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-718579
Filing Date
2016-09-23
Accepted
2016-09-23 17:28:02
Documents
8
Period of Report
2016-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d239031d8k.htm 8-K 19119
2 EX-1.1 d239031dex11.htm EX-1.1 200200
3 EX-5.1 d239031dex51.htm EX-5.1 6679
4 EX-99.1 d239031dex991.htm EX-99.1 7410
5 EX-99.2 d239031dex992.htm EX-99.2 7501
6 GRAPHIC g239031g0923082839002.jpg GRAPHIC 2816
7 GRAPHIC g239031g0923083536350.jpg GRAPHIC 2816
8 GRAPHIC g239031snap0001.jpg GRAPHIC 3002
  Complete submission text file 0001193125-16-718579.txt   254731
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 161900615
SIC: 2834 Pharmaceutical Preparations